Commentary: 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings

Front Psychiatry. 2021 Jan 15:11:592593. doi: 10.3389/fpsyt.2020.592593. eCollection 2020.

Bruno Etain^{1

2

3}, Emilie Olie^{3

4}, Philippe Courtet^{3

4}, Ophelia Godin^{3

5}, Marion Leboyer^{3

5}

¹ Université de Paris - INSERM UMRS 1144, Paris, France.
² Assistance Publique des Hôpitaux de Paris, APHP.Nord, DMU Neurosciences, GHU Saint Louis-Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, France.
³ Fondation Fondamental, Créteil, France.
⁴ Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, PSNREC, Univ Montpellier, INSERM, CHU de Montpellier, Montpellier, France.
⁵ Université Paris Est Créteil, Inserm U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Créteil, France.

No abstract available

Keywords: antipsychotics; bipolar disorder; lithium; metabolic syndrome; suicide.

Publication types